FindTrial
Sign In

PEDIATRIC INTENSIVE CARE C PROTEIN HEMOSTASIS STUDY - ND

PEDIATRIC INTENSIVE CARE C PROTEIN HEMOSTASIS STUDY - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-014420-37-IT
Enrollment
Unknown
Registered
2009-11-02
Start date
2009-09-15
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SEVERE SEPSIS/ SEPTIC SHOCK

Interventions

Trade Name: CEPROTIN Pharmaceutical Form: Powder and solvent for solution for injection INN or Proposed INN: Protein C Concentration unit: IU/kg international unit(s)/kilogram Concentration type: equa

Sponsors

AZIENDA OSPEDALIERA ISTITUTI CLINICI DI PERFEZIONAMENTO DI MILANO
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: SEVERE SEPSIS/ SEPTIC SHOCK; AGE: 6 MONTHS - 16 YEARS Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: TREATMENT WITH ATIII

Design outcomes

Primary

MeasureTime frame
Main Objective: TO EVALUATE THE ANTINFLAMMATORY AND ANTITHROMBOTIC EFFECT OF PROTEIN C;Secondary Objective: TO EVALUATE MORBILITY AND ORGAN FAILURE;Primary end point(s): TO EVALUATE THE ANTINFLAMMATORY AND ANTITHROMBOTIC EFFECT OF PROTEIN C—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026